Crescent Biopharma Reports $24.6M Loss
Update: 2025-11-06
Description
Crescent Biopharma, based in Waltham, Massachusetts, reported a significant loss of $24.6 million for Q3, translating to a loss of $1.27 per share. This fell short of analysts expectations, potentially impacting investor confidence and stock performance. The company faces scrutiny due to the larger-than-anticipated loss, indicating potential sector challenges or internal issues.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
